Trials / Not Yet Recruiting
Not Yet RecruitingNCT06028217
Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
A Prospective Study on Pathogen Investigation, Risk Factors, and Prognostic Factors Analysis of Hospital Acquired Pneumonia (HAP)
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective and observatory study is to learn about the pathogen, clinical manifestations, prognosis, treatment and antibiotic resistance of bacteria in hospital-acquired pneumonia patients in China. The main purposes of this study are: 1. clarify the regional differences and changes over time in the pathogen spectrum and antibiotic resistance rate among HAP patients in China; 2. build a continuously optimized nationwide HAP pathogen and antibiotic resistance surveillance network; 3. identify the molecular epidemiology of common pathogens
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | prognosis status | observatory; patients will be divided into survival group and mortality group according to their prognosis at day 28 |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2027-09-30
- Completion
- 2027-12-31
- First posted
- 2023-09-08
- Last updated
- 2023-09-08
Source: ClinicalTrials.gov record NCT06028217. Inclusion in this directory is not an endorsement.